drugset / Trial / NCT00273052

COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension

NCT00273052

Phase 3 Completed 514 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was designed to determine whether treatment with COREG MR is more effective at maintaining a better lipid profile than treatment with TOPROL-XL for hypertension.

Timeline

Start
2006-01-05
Primary completion
2007-12-01
Completion
2007-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified
Comparator Metoprolol Other / unclassified

Indications